FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Dilip Davda, Hem Securities, Jainam Broking limited, Nirmal Bang and Swastika Investmart Ltd have given "Apply" recommendation to Fusion Micro Finance IPO. Angel One, Capital Market and Religare Broking Limited have "Neutral" view about the IPO. InvestorGain.com recommend to "Avoid" the IPO.ICICI Direct has "Not Rated" the IPO.
Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 5 | 0 | 3 | 1 | 1 |
% | 50.00 | 0.00 | 30.00 | 10.00 | 10.00 |
Reviewer | Recommendation | Past Reviews |
---|---|---|
Angel One | Neutral | |
Capital Market | Neutral | |
Dilip Davda | Apply | |
Hem Securities | Apply | |
ICICI Direct | Not Rated | |
Jainam Broking limited | Apply | |
Nirmal Bang | Apply | |
Religare Broking Limited | Neutral | |
Swastika Investmart Ltd | Apply | |
InvestorGain.com | Avoid |
The Captial Market (CapitalMarket.com) rating for Fusion Micro Finance IPO is 42. Their analysis recommends Avoid, however active risk seekers can try for the IPO.
Reviewer | Rating Score | Rating |
---|---|---|
Capital Market | 42 | Avoid, however active risk seekers can try |
[Dilip Davda] Over the years, the company has gained credentials to be among the first two MFIs in India. Though it marked growth in top lines, it posted declining profits amidst the pandemic, natural calamities, and expansion spending from FY20 to FY22. It is on a recovery path as indicated by Q1 of FY23 and based on these earnings, the issue is lucratively priced. Investors may consider an investment with a medium to long-term perspective. Read detail review...
Fusion Micro Finance IPO Reviews, analysis and views by popular members. Read Fusion Micro Finance Limited IPO reviews by retail investors to find recommended ipo to buy.
Post Recommendation Manage Your IPO Reviews
Review By | Apply | May Apply | Neutral | Avoid |
---|---|---|---|---|
Count | 3 | 0 | 1 | 4 |
% | 37.50 | 0.00 | 12.50 | 50.00 |
Member | Review |
---|---|
Gurudev |
Avoid Avoid November 4, 2022 12:53:14 PM |
Nomee |
Avoid This IPO Will Loot you, Will Koooooot you. November 3, 2022 7:06:15 PM |
B.M.SURANA IPO Guru (2700+ Posts, 5300+ Likes) |
Avoid High Price |
Abhijeet Kumar |
Avoid Instead of applying in such poor quality IPO like Fusion and Global health its better to buy good quality scrips from secondary market which are trading at cheap valuations. Few of my suggestions to buy would be : Sanofi India, Johnson Control, Tamilnad Merchantile Bank, GE T&D India, Bector Foods, Railtel etc, November 3, 2022 2:18:05 AM |
Crow IPO Mentor (900+ Posts, 1000+ Likes) |
Neutral Microfinance for a niche consumer base looks good on paper but is hardly a profitable business, especially in a complex country like India with its skewed demographic census. But finance firms have historically been the markets' darlings, so it's possible this may give a listing pop. How you traverse that is a question in itself. May apply based on last day's QIB subscription figures and GMP sustenance. November 2, 2022 2:20:20 PM |
Rajesh s. IPO Mentor (600+ Posts, 700+ Likes) |
Apply for Short Term at Upper Price Band 𝘈𝘱𝘱𝘭𝘺 𝘧𝘰𝘳 𝘭𝘪𝘴𝘵𝘪𝘯𝘨 𝘨𝘢𝘪𝘯. November 1, 2022 1:56:09 PM |
Top Contributor |
Apply for Listing Gain at Upper Price Band May Apply November 1, 2022 9:24:50 AM |
arunARUN IPO Guru (2000+ Posts, 1700+ Likes) |
Apply for Short Term at Cut-off Price Attractive post IPO price by book value ratio of 1.35. In comprasion to listed microfinance companies it is very attractive. |
Post Recommendation Manage Recommendations
Note:
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|